Best drugmaker podcasts we could find (Updated July 2017)   Drugmaker public [search 0]

No series here

Try another search?

Broken tape
Loading …
 
The United States is the leader in biopharmaceutical innovation and in guaranteeing that our prescription drugs are safe and effective. For decades, the Food and Drug Administration (FDA) has enforced a strict set of rules and protocols that allow Americans to have confidence in the drugs that they buy. Other countries do not have the same rigo ...…
 
W
WorkCompAcademy | Weekly News
 
Rene Thomas Folse, JD, Ph.D. is the host for this edition which reports on the following news stories. Court Affirms Terms of Liberty Mutual "Guaranteed Cost" Policy, LA Hospital Pays $42 Million in Kickback Case, Targeting Transnational Organized Medical Fraud, DWC Updates DMEPOS Fee Schedule, WCIRB Launches 2018 Experience Modification Estima ...…
 
A breakthrough cancer therapy that can wipe out leukemia in some deathly ill children and young adults comes with an expensive, long-lasting side effect.The blood cancer treatment, called CAR-T, is made by Novartis AG and is on the brink of approval after a panel of advisers to the U.S. Food and Drug Administration backed it Wednesday in a 10-0 ...…
 
More than a decade ago, Italy tried a novel approach to help bring down drug costs: asking pharmaceutical companies to return money to the national health system if some of their medicines failed to work as expected. The effort largely flopped.The Trump administration is now considering whether to encourage a similar approach. Pharmaceutical ex ...…
 
(Bloomberg) -- Richard Ausness, a professor at the University of Kentucky School of Law, and Jodi Avergun, partner at Cadwalader and former chief of staff of the DEA, discuss how drug makers are being sued for the opioid crisis in America. They speak with Greg Stohr and Michael Best on Bloomberg Radio’s “Bloomberg Law”.…
 
Federal Court Blocks Trumps EPA on Air Pollution, Volvo Abandoning the Engine by 2019. Going Green Taking More Green. Oreo and It's Crazy New Flavor Contest.
 
(Bloomberg) -- Robert Langreth, a reporter for Bloomberg News, discusses a new IRS probe into the tax-exempt status of a charity funded by pharmaceutical companies, which threatens a pipeline allowing pharmaceutical companies to help patients pay for expensive drugs. He speaks with Greg Stohr and June Grasso on Bloomberg Radio's "Bloomberg Law."…
 
(Bloomberg) -- Robert Langreth, a reporter for Bloomberg News, discusses a new IRS probe into the tax-exempt status of a charity funded by pharmaceutical companies, which threatens a pipeline allowing pharmaceutical companies to help patients pay for expensive drugs. He speaks with Greg Stohr and June Grasso on Bloomberg Radio's "Bloomberg Law."…
 
P
P&L With Pimm Fox and Lisa Abramowicz
 
Brian Egger, senior gaming and lodging analyst at Bloomberg Intelligence, says Marriott has had a 20 percent inbound decline from Mexico and the Middle East since Trump announced plans for a travel ban. Bloomberg's Robert Langreth talks about the IRS probe into a charity funded by drugmakers. Ex-U.S. Transportation Secretary James Burnley tells ...…
 
P
P&L With Pimm Fox and Lisa Abramowicz
 
Brian Egger, senior gaming and lodging analyst at Bloomberg Intelligence, says Marriott has had a 20 percent inbound decline from Mexico and the Middle East since Trump announced plans for a travel ban. Bloomberg's Robert Langreth talks about the IRS probe into a charity funded by drugmakers. Ex-U.S. Transportation Secretary James Burnley tells ...…
 
I
Inside Daily Brief Newsletter
 
You are listening to the Inside news letter's daily brief. Use Newsbeat app to listen to great news articles from the webSenate Republican leaders have shelved a vote on the health care reform because GOP senators are at odds regarding the repeal of Obamacare. Senate Republican leader Mitch McConnell announced the delay after it became clear th ...…
 
You are listening to the Inside news letter's daily brief. Use Newsbeat app to listen to great news articles from the webSenate Republican leaders have shelved a vote on the health care reform because GOP senators are at odds regarding the repeal of Obamacare. Senate Republican leader Mitch McConnell announced the delay after it became clear th ...…
 
A global cyber-attack that affected companies around the world may have started via corrupted updates for some accounting software. Fingers are increasingly pointing to a piece of Ukrainian tax-filing software, MEDoc, as the source of the infection, although the company denies it. Malware generally infiltrates networks via email attachments tha ...…
 
A global cyber-attack that affected companies around the world may have started via corrupted updates for some accounting software. Fingers are increasingly pointing to a piece of Ukrainian tax-filing software, MEDoc, as the source of the infection, although the company denies it. Malware generally infiltrates networks via email attachments tha ...…
 
W
WorkCompAcademy | Weekly News
 
Rene Thomas Folse, JD, Ph.D. is the host for this edition which reports on the following news stories.Supreme Court Ruling Expedites New Drugs, Attorney General Responds to SB 1160 Challenge, East Bay Restaurant Owners Plead Guilty, So. Cal. Dentist Charged with Insurance Fraud, Is it Medical Research or a Kickback Scheme?, DWC Approves Telemed ...…
 
Tonight Curtis is joined by Family and Children's Association President Dr. Jeff Reynolds, NY Daily News Columnist Gersh Kuntzman, and Record Columnist Mike Kelly.
 
The high cost of drug development, the challenge of translational research, and continuing concerns with R&D efficiency has had entrepreneurs, investors, and drugmakers open to experimenting with new models of innovation. COI Pharmaceuticals, born out of a collaboration between the pharmaceutical giant GlaxoSmithKline and Avalon Ventures, is on ...…
 
P
P&L With Pimm Fox and Lisa Abramowicz
 
Bloomberg Gadfly columnist Shira Ovide talks about Amazon's deal to buy Whole Foods and what it means for Amazon's foray into food. Bloomberg's Katherine Chiglinsky discusses GE's $31 billion pension shortfall. Michael Rea, the founder and CEO of RX Savings Solutions, talks about news that Nevada is forcing drugmakers to reveal insulin pricing. ...…
 
P
P&L With Pimm Fox and Lisa Abramowicz
 
Bloomberg Gadfly columnist Shira Ovide talks about Amazon's deal to buy Whole Foods and what it means for Amazon's foray into food. Bloomberg's Katherine Chiglinsky discusses GE's $31 billion pension shortfall. Michael Rea, the founder and CEO of RX Savings Solutions, talks about news that Nevada is forcing drugmakers to reveal insulin pricing. ...…
 
The production of biologics is costly and takes time. Dyadic International has developed a proprietary manufacturing process that replaces the use of Chinese hamster ovary cells, long used to produce protein therapeutics, with a fungus that has a long history in industrial biotechnology applications. The company believes its process can produce ...…
 
T
This Week in Drugs
 
In honor of the 100th episode of TWiD, the entire team spends some time reflecting on our favorite parts of the podcast and sharing some of the best bloopers with you! News Updates: Formerly incarcerated people to benefit from $6 million in Prop 47 funds NFL Bans Marijuana Ads While Allowing Liquor Spots FDA Calls On Drugmaker To Pull A Powerfu ...…
 
Two years ago, a mental health advocate named Steve McCaffrey stood at a lectern in the Indiana statehouse, testifying in favor of an addiction treatment bill. After years of rising overdose rates, lawmakers in the health committee were taking action to combat the opioid epidemic. And they often turned to McCaffrey, who leads Mental Health Amer ...…
 
Bloomberg Markets with Carol Massar and Cory Johnson.GUEST:Cynthia KoonsHealthcare Reporter Bloomberg News Discussing Mylan NV facing an increasing backlash over its handling of the EpiPen pricing controversy, as a top proxy adviser urged shareholders to oust the drugmaker’s board.
 
Bloomberg Markets with Carol Massar and Cory Johnson.GUEST:Cynthia KoonsHealthcare Reporter Bloomberg News Discussing Mylan NV facing an increasing backlash over its handling of the EpiPen pricing controversy, as a top proxy adviser urged shareholders to oust the drugmaker’s board.
 
Bloomberg Markets with Carol Massar and Cory Johnson.GUEST:Cynthia KoonsHealthcare Reporter Bloomberg News Discussing Mylan NV facing an increasing backlash over its handling of the EpiPen pricing controversy, as a top proxy adviser urged shareholders to oust the drugmaker’s board.
 
W
WorkCompAcademy | Weekly News
 
Rene Thomas Folse, JD, Ph.D. is the host for this edition which reports on the following news stories. Teva Settles Santa Clara/Orange County Opioid Suit, Ohio Files Lawsuit Against Opioid Drugmakers, Feds Double Down on Price Gouging Drugmaker, Two Lies are Separate Perjury Counts, Janitorial Owner Faces $32M Fraud Case, Data Analytics Identif ...…
 
Speed
Series preference
1x
1x
Volume
100%
/

Google login Twitter login Classic login